Ahmed Hassan

Ahmed Hassan serves as a key procurement professional within the National Heart, Lung, and Blood Institute (NHLBI), supporting the agency’s mission to advance biomedical research through strategic acquisition of analytical laboratory instrumentation, specialized research services, and biologic data infrastructure. He manages complex contracts for high-precision scientific equipment, bioinformatics systems, and technical support services critical to precision medicine and single-cell genomics initiatives. His acquisitions span the full lifecycle of research enablement—from instrument procurement to data analysis platforms—ensuring NHLBI’s scientific community has access to cutting-edge capabilities essential for cardiovascular, pulmonary, and hematologic research. Hassan maintains established relationships with a network of research-focused institutions and technical service providers, including the University of Mississippi Medical Center, Wake Forest University Health Sciences, and TDA Research, Inc. His contracting patterns reflect deep collaboration with academic medical centers and specialized engineering firms capable of delivering customized research solutions. These partnerships are typically structured as research support contracts, service agreements, and instrumentation procurement vehicles that prioritize scientific rigor and technical adaptability over commoditized supply. His procurement portfolio shows no reliance on socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a mission-driven emphasis on technical capability and scientific alignment over socioeconomic preferences, aligning with NHLBI’s need for highly specialized expertise not always available within small business pools. Hassan’s primary NAICS focus areas include analytical laboratory instrument manufacturing (334516), research and development in life sciences (541715), and computer systems design services (541512). He routinely procures next-generation sequencing platforms, mass spectrometers, flow cytometers, and high-performance computing systems for genomic and proteomic analysis, demonstrating deep technical fluency in life sciences infrastructure and data-intensive research environments.